Hm Payson & CO Novartis Ag Transaction History

Hm Payson & CO

$5.81 Billion
Q3 2024

A detailed history of Hm Payson & CO transactions in Novartis Ag stock. As of the latest transaction made, Hm Payson & CO holds 3,163 shares of NVS stock, worth $311,397. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,163

Previous 2,805 12.76%

Holding current value

$311,397

Previous $298,000 21.81%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$106.13 - $120.89 $37,994 - $43,278	358 Added 12.76%	3,163 $363,000
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $13,840 - $15,231	-150 Reduced 5.08%	2,805 $283,000
Q3 2023 Nov 06, 2023	BUY	$94.73 - $105.13 $49,733 - $55,193	525 Added 21.6%	2,955 $300,000
Q2 2023 Jul 17, 2023	BUY	$92.52 - $104.91 $2,313 - $2,622	25 Added 1.04%	2,430 $245,000
Q1 2023 Apr 18, 2023	SELL	$80.03 - $92.81 $58,501 - $67,844	-731 Reduced 23.31%	2,405 $221,000
Q4 2022 Feb 06, 2023	SELL	$75.55 - $92.52 $117,329 - $143,683	-1,553 Reduced 33.12%	3,136 $284,000
Q3 2022 Oct 25, 2022	BUY	$74.61 - $87.26 $96,619 - $113,001	1,295 Added 38.16%	4,689 $356,000
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $19,727 - $22,968	-245 Reduced 6.73%	3,394 $286,000
Q1 2022 May 12, 2022	BUY	$80.11 - $90.62 $16,823 - $19,030	210 Added 6.12%	3,639 $319,000
Q4 2021 Feb 15, 2022	BUY	$79.7 - $88.13 $32,039 - $35,428	402 Added 13.28%	3,429 $300,000
Q3 2021 Nov 30, 2021	BUY	$81.78 - $95.14 $2,289 - $2,663	28 Added 0.93%	3,027 $248,000
Q2 2021 Aug 17, 2021	SELL	$85.24 - $94.15 $15,939 - $17,606	-187 Reduced 5.87%	2,999 $274,000
Q1 2021 Jun 15, 2021	BUY	$83.5 - $98.47 $47,845 - $56,423	573 Added 21.93%	3,186 $272,000
Q4 2020 Mar 10, 2021	SELL	$78.07 - $94.43 $43,719 - $52,880	-560 Reduced 17.65%	2,613 $247,000
Q3 2020 Dec 21, 2020	BUY	$82.14 - $91.0 $24,395 - $27,027	297 Added 10.33%	3,173 $276,000
Q1 2020 Jul 01, 2020	SELL	$70.67 - $99.01 $14,134 - $19,802	-200 Reduced 6.5%	2,876 $237,000
Q4 2019 Feb 18, 2020	SELL	$84.35 - $95.37 $493,110 - $557,533	-5,846 Reduced 65.52%	3,076 $291,000
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $50,040 - $55,142	-585 Reduced 6.15%	8,922 $775,000
Q2 2019 Aug 15, 2019	SELL	$75.4 - $92.8 $61,451 - $75,632	-815 Reduced 7.9%	9,507 $868,000
Q1 2019 Jul 31, 2019	BUY	$75.32 - $86.15 $777,453 - $889,240	10,322 New	10,322 $992,000
Q4 2018 Feb 15, 2019	SELL	$73.66 - $82.02 $702,863 - $782,634	-9,542 Closed	0 $0
Q3 2018 Nov 30, 2018	SELL	$66.94 - $77.43 $10,041 - $11,614	-150 Reduced 1.55%	9,542 $822,000
Q2 2018 Aug 27, 2018	SELL	$64.91 - $73.36 $2,596 - $2,934	-40 Reduced 0.41%	9,692 $732,000
Q1 2018 May 14, 2018	SELL	$70.39 - $84.15 $12,107 - $14,473	-172 Reduced 1.74%	9,732 $787,000
Q4 2017 Feb 16, 2018	BUY	$72.33 - $77.64 $16,057 - $17,236	222 Added 2.29%	9,904 $831,000
Q3 2017 Nov 06, 2017	BUY	$74.14 - $77.27 $717,823 - $748,128	9,682	9,682 $831,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account